Harlan Waksal Lyra Therapeutics, Inc. (LYRA) insider trading activity

LYRA Quotes by TradingView

Harlan Waksal is Executive Chair of Lyra Therapeutics, Inc.. Currently has a direct ownership of 536,966 shares of LYRA, which is worth approximately $150,350. The most recent transaction as insider was on Mar 18, 2024, when has been sold 275,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 537K
0% 3M change
126.6% 12M change
Total Value Held $150,350

Harlan Waksal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
BUY
Grant, award, or other acquisition
-
275,000 Added 33.87%
536,966 Common Stock
Nov 10 2023
BUY
Open market or private purchase
$74,000 $2.96 p/Share
25,000 Added 8.71%
261,966 Common Stock
Apr 12 2022
BUY
Open market or private purchase
$999,996 $4.22 p/Share
236,966 Added 50.0%
236,966 Common Stock

Also insider at

KDMN
Kadmon Holdings, Inc.
President, CEO
HW

Harlan Waksal

Executive Chair
New York, NY

Track Institutional and Insider Activities on LYRA

Follow Lyra Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYRA shares.

Notify only if

Insider Trading

Get notified when an Lyra Therapeutics, Inc. insider buys or sells LYRA shares.

Notify only if

News

Receive news related to Lyra Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LYRA